Company intelligence / Profile preview

SimpleC

Atlanta, Georgia, United Statessimplec.com ↗

Ownership: Private
Development stage: Commercial

Overview

The SimpleC digital therapeutic platform delivers non-drug, media-based behavioral therapies for individuals with complex diagnoses such as dementia. It uses AI-driven personalization to improve care routines and outcomes. The company’s solutions are deployed commercially for both individual/family use and clinical settings; no traditional clinical trial results are reported but the product has demonstrated impact on mood and routine adherence in real-world use.

Therapeutic areas: PsychiatryNeurology
Modalities: Non-pharmacological therapy (Digital Therapeutics)Device (Software platform)
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on SimpleC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SimpleC.

Explore the full profile